JPH0232273B2 - - Google Patents
Info
- Publication number
- JPH0232273B2 JPH0232273B2 JP63285563A JP28556388A JPH0232273B2 JP H0232273 B2 JPH0232273 B2 JP H0232273B2 JP 63285563 A JP63285563 A JP 63285563A JP 28556388 A JP28556388 A JP 28556388A JP H0232273 B2 JPH0232273 B2 JP H0232273B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- acid
- arg
- methoxy
- trimethylbenzenesulfonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 4-Methoxy-2,3,6-trimethylbenzenesulfonyl halide Chemical class 0.000 claims description 24
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 19
- 238000000034 method Methods 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 14
- 108090000765 processed proteins & peptides Proteins 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 125000006239 protecting group Chemical group 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 239000004475 Arginine Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 6
- 238000010306 acid treatment Methods 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 238000000921 elemental analysis Methods 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- ZUSSTQCWRDLYJA-UHFFFAOYSA-N n-hydroxy-5-norbornene-2,3-dicarboximide Chemical compound C1=CC2CC1C1C2C(=O)N(O)C1=O ZUSSTQCWRDLYJA-UHFFFAOYSA-N 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- FUSAEZSSVDNYPO-LBPRGKRZSA-N (2s)-5-[[amino-[(4-methoxy-2,3,6-trimethylphenyl)sulfonylamino]methylidene]amino]-2-azaniumylpentanoate Chemical compound COC1=CC(C)=C(S(=O)(=O)NC(N)=NCCC[C@H](N)C(O)=O)C(C)=C1C FUSAEZSSVDNYPO-LBPRGKRZSA-N 0.000 description 3
- DWLYVEYCCPEHLX-UHFFFAOYSA-N 4-methoxy-2,3,6-trimethylbenzenesulfonyl chloride Chemical compound COC1=CC(C)=C(S(Cl)(=O)=O)C(C)=C1C DWLYVEYCCPEHLX-UHFFFAOYSA-N 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- JXNRXNCCROJZFB-RYUDHWBXSA-N Tyr-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JXNRXNCCROJZFB-RYUDHWBXSA-N 0.000 description 3
- 150000001483 arginine derivatives Chemical class 0.000 description 3
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 3
- 238000010531 catalytic reduction reaction Methods 0.000 description 3
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 229940098779 methanesulfonic acid Drugs 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- 238000010647 peptide synthesis reaction Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- HNKJADCVZUBCPG-UHFFFAOYSA-N thioanisole Chemical compound CSC1=CC=CC=C1 HNKJADCVZUBCPG-UHFFFAOYSA-N 0.000 description 3
- AWONIZVBKXHWJP-UHFFFAOYSA-N 1-methoxy-2,3,5-trimethylbenzene Chemical compound COC1=CC(C)=CC(C)=C1C AWONIZVBKXHWJP-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- JXNRXNCCROJZFB-UHFFFAOYSA-N Di-Me ester-(2R, 3E)-Phytochromobilin Natural products NC(N)=NCCCC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 JXNRXNCCROJZFB-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 2
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 2
- 108010053037 kyotorphin Proteins 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
- VHNBNECUVQXBQA-UHFFFAOYSA-N methylsulfanylbenzene;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CSC1=CC=CC=C1 VHNBNECUVQXBQA-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- XTHPWXDJESJLNJ-UHFFFAOYSA-N sulfurochloridic acid Chemical compound OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 2
- QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 description 1
- CNBUSIJNWNXLQQ-NSHDSACASA-N (2s)-3-(4-hydroxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 CNBUSIJNWNXLQQ-NSHDSACASA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- JDWREWOCOCHHOO-UHFFFAOYSA-N 4-methoxy-2,3,6-trimethylbenzenesulfonic acid Chemical group COC1=CC(C)=C(S(O)(=O)=O)C(C)=C1C JDWREWOCOCHHOO-UHFFFAOYSA-N 0.000 description 1
- 102400000237 Alpha-neoendorphin Human genes 0.000 description 1
- 101800001617 Alpha-neoendorphin Proteins 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 244000186140 Asperula odorata Species 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- 108010065372 Dynorphins Proteins 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 235000008526 Galium odoratum Nutrition 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 102100029251 Phagocytosis-stimulating peptide Human genes 0.000 description 1
- RVQDZELMXZRSSI-IUCAKERBSA-N Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 RVQDZELMXZRSSI-IUCAKERBSA-N 0.000 description 1
- 102100024622 Proenkephalin-B Human genes 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 1
- 108010086019 Secretin Proteins 0.000 description 1
- 102100037505 Secretin Human genes 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 102400000096 Substance P Human genes 0.000 description 1
- 101800003906 Substance P Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 108010084754 Tuftsin Proteins 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- BLWYXBNNBYXPPL-YFKPBYRVSA-N methyl (2s)-pyrrolidine-2-carboxylate Chemical compound COC(=O)[C@@H]1CCCN1 BLWYXBNNBYXPPL-YFKPBYRVSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- MQBCDKMPXVYCGO-FQBKTPCVSA-N mycothiol Chemical compound CC(=O)N[C@@H](CS)C(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O MQBCDKMPXVYCGO-FQBKTPCVSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 229960002101 secretin Drugs 0.000 description 1
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical compound [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- IESDGNYHXIOKRW-LEOABGAYSA-N tuftsin Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(O)=O IESDGNYHXIOKRW-LEOABGAYSA-N 0.000 description 1
- 229940035670 tuftsin Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- KZTDMJBCZSGHOG-XJIZABAQSA-N α-neoendorphin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 KZTDMJBCZSGHOG-XJIZABAQSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Description
本発明は、グアニジノ基の保護基として有用な
4−メトキシ−2,3,6−トリメチルベンゼン
スルフオニルハライドに関する。
グアニジノ基
The present invention relates to 4-methoxy-2,3,6-trimethylbenzenesulfonyl halide useful as a protecting group for guanidino groups. guanidino group
【式】を含有する原
料化合物(例えばアルギニンなど)を用いてペプ
チドを製造するためには、グアニジノ基を保護し
ておく必要がある。グアニジノ基の保護は、従
来、ニトロ基またはトシル基を導入することによ
り行なわれてきた。
これらの従来法においては、保護基を脱離する
際の収率が低く、また、トシル基を脱離させるに
は、液体アンモニア−金属ナトリウムあるいは無
水弗化水素などを用い強い条件で行なわなければ
ならないのでペプチドの他の部分が分離し副生物
が生じ、目的とするペプチドの収率の低下をきた
す等の欠点があつた。
本発明者らは、これら欠点を解消する方法とし
て先にグアニジノ基の保護基として、メタンスル
フオン酸で容易に除去できるp−メトキシベンゼ
ンスルフオニル、メジチレンスルフオニル基等を
利用する方法(特開昭51−100030)を紹介し、実
用に供した。その後も、本発明者らはグアニジノ
基の保護について研究をつづけたところ、グアニ
ジノ基の保護基として、4−メトキシ−2,3,
6−トリメチルベンゼンスルフオニル基が、さら
に緩和な酸処理によつて、該保護基を脱離できる
ことを見い出し、ペプチド製造に有用な本発明の
アルギニン誘導体を完成した。
すなわち本発明は、4−メトキシ−2,3,6
−トリメチルベンゼンスルフオニルハライドであ
る。
本発明の化合物は、グアニジノ基含有化合物、
たとえばアルギニンのグアニジノ基に導入し、次
の一般式()
(式中、RはHまたはα−アミノ基の保護基を
表わす)で示されるアルギニン誘導体としてペプ
チド合成に用いられる。
4−メトキシ−2,3,6−トリメチルベンゼ
ンスルフオニルハロゲニドとしては、クロリド、
フルオリド、ブロミド、ヨージドのいずれでもよ
い。たとえば、4−メトキシ−2,3,6−トリ
メチルベンゼンスルフオニルクロリドは、後述の
実施例のように、2,3,5−トリメチルアニソ
ールに、クロルスルフオン酸を反応させることに
より異性体を、生成することなく、結晶として得
ることができる。
グアニジノ基含有化合物のグアニジノ基の4−
メトキシ−2,3.6−トリメチルベンゼンスルフ
オニル基を導入するに際しては、グアニジノ基含
有化合物のα−アミノ基を保護して反応に供せら
れる。このα−アミノ基の保護は、従来から公知
の保護基、例えば一般式()におけるRで示さ
れる保護基としてカルボベンゾキシ基、p−ニト
ロベンジルオキシカルボニル基、p−メトキシベ
ンジルオキシカルボニル基、t−ブトキシカルボ
ニル基、t−アミロキシカルボニル基、9−フル
オレニルメトキシカルボニル基、イソニコチニル
オキシカルボニル基、O−ニトロフエニルスルフ
エニル基、2−(p−ビフエニル)−イソプロピル
オキシカルボニル基を常法により導入したものが
あげられ、特にアルギニンをカルボベンゾキシ
基、t−ブトキシカルボニル基で保護したものが
有利に用いられる。
次に、α−アミノ基が保護されたグアニジノ基
含有化合物のグアニジノ基に4−メトキシ−2,
3,6−トリメチルベンゼンスルフオニル基を反
応させる。この反応はグアニジノ基含有化合物に
4−メトキシ−2,3,6−トリメチルベンゼン
スルフオン酸基をグアニジノ基含有化合物1当量
に対し約1〜5当量、さらに好ましくは約1〜2
当量になるように反応させるのがよい。4−メト
キシ−2,3,6−トリメチルベンゼンスルフオ
ニル基の導入は、塩基の存在下に行うのが好まし
い。塩基としては、たとえば水酸化ナトリウム、
水酸化カリウム、水酸化リチウムなどが挙げら
れ、グアニジノ基含有化合物1当量に対し約1〜
10当量、さらに好ましくは約1〜5当量用いられ
る。該反応は、通常適当な溶媒たとえば、水、ア
セトン、ジオキサン、ジメチルホルムアミド、テ
トラヒドロフラン、あるいはそれらの混合溶媒中
などで行うのがよい。該反応は、−10℃乃至25℃、
好ましくは−5℃乃至10℃で行なわれる。
このようにして得られる4−メトキシ−2,
3,6−トリメチルベンゼンスルフオニル基で保
護されたグアニジノ基を有する化合物は、遊離の
ままあるいは常法に従つてシクロヘキシルアミ
ン、ジシクロヘキシルアミン、ナトリウムなどの
塩としてペプチド縮合に供せられる。
本発明において、グアニジノ基を4−メトキシ
−2,3,6−トリメチルベンゼンスルフオニル
基で保護されたグアニジノ基を有する化合物と
は、前記の一般式()で示されるアルギニン誘
導体およびその塩である。
このようにして得られる4−メトキシ−2,
3,6−トリメチルベンゼンスルフオニル基で保
護されたグアニジノ基を有する化合物は常套手段
によりペプチド縮合反応に用いられる。この常套
手段としては、例えばM.Bodansky及びM.A.
Ondetti著、ペプチド・シンセシス(Peptide
Synthesis),Inter science.New York,1966
年;F.M.Finn及びK.Hofmann著ザ・プロテイン
ズ(The Proteins),第2巻、H.Nenrath,R.L.
Hill編集,Academic Press Inc.New york,
1976年;泉屋信夫他著“ペプチド合成”丸善(株)
1975年などに記載された方法、たとえばアジド
法、クロライド法、酸無水物法、混酸無水物法、
DCC法、活性エステル法、ウツドワード試薬K
を用いる方法、カルボジイミダゾール法、酸化還
元法、DCC/HONB法などが挙げられる。
次に、ペプチド縮合後、本発明の保護基を酸に
よつて脱離させる。この脱離方法としては、無水
弗化水素法、メタンスルフオン酸法、トリフルオ
ロメタンスルフオン酸法等の公知の酸処理方法が
適用できる。さらに、本発明方法の場合には、新
しい酸処理方法としてトリフルオロ酢酸が有利に
使用でき、特にチオアニソールまたはアニソール
の存在下でトリフルオロ酢酸を用いると脱離反応
が非常に有利に進行する。
上記のトリフルオロ酢酸およびチオアニソー
ル、アニソールは溶媒をかね保護基を脱離しうる
に十分な量を用いればよい。たとえば、保護され
たグアニジノ基を有する化合物1当量に対し1〜
105当量、さらに好ましくは1〜103当量用いら
れ、脱離反応は、酢酸、クロロホルム、メチレン
クロリドなどの溶媒中で行つてもよく、また温度
は−10℃乃至300℃程度、さらに好ましくは10℃
乃至100℃程度で行なわれる。
本発明の化合物は、グアニジノ基を有するいか
なるペプチドの製造にも適用できる。具体的な例
としては、Des−Gly10−[D−eu6]−LH−RH−
ethylamide(特公昭53−14072参照)、Des−Gly10
−LH−RH−ethylamide(特公昭53−24423参
照),Tuftsin[Nature,228672(1970)参照],
Substance P.Kyotorphinなどの生理活性ペプチ
ドを有利に製造できる。その他のペプチドとし
て、MSH,ACTH,Glucagon Secretin
Bradykinin,Dynorphin,α−Neoendorphinお
よびそれらの活性断片なども有利に製造できる。
4−メトキシ−2,3,6−トリメチルベンゼ
ンスルフオニル基は、従来行なわれていた酸処理
によるグアニジノ保護基の脱離方法はもちろんの
こと、さらに緩和な条件下でも容易に脱離され
る。例えば、トリフルオロ酢酸のような緩和な酸
処理は、従来知られたグアニジノ保護基の脱離に
は適用することができないが、4−メトキシ−
2,3,6−トリメチルベンゼンスルフオニル基
で保護した場合はよく脱離が進行し充分に適用で
きる。ところで、従来の方法により、p−メトキ
シベンゼンスルフオニル基、メジチレンスルフオ
ニル基でグアニジノ基を保護しペプチド縮合後、
メタンスルフオン酸を用いて保護基を脱離する場
合、そのペプチド中に、アスパラギンやアスパラ
ギン酸残基を含有する場合には、サクシンイミド
型の副反応が生ずることがあり、またセリンやス
レオニン残基が存在するとN→Oアシル転位が起
る。本発明方法の場合、これらのアミノ基残基を
含むペプチドであつてもトリフルオロ酢酸のよう
な緩和な酸を用いることにより上記のような副反
応が起こることなく脱離することができる。
次に、本発明を実施例および試験例を挙げてさ
らに詳しく説明する。なお、本明細書においては
4−メトキシ−2,3,6−トリメチルベンゼン
スルフオニル基をMtrと略記することがあり、ま
たアミノ酸、ペプチド、保護基、活性基等に関
し、IUPAC−IUB commission on Biological
Nomenclatureに基づく略号あるいは当該分野に
おける慣用略号で表示する場合がある。それらを
例示する。
pGlu:ピログルタミン酸;His:ヒスチジン;
Trp:トリプトフアン;Ser:セリン;Tyr:チ
ロシン;Leu:ロイシン、Gly:グリシン;
Arg:アルギニン;Pro:プロリン;Lys:リジ
ン;GlN:グルタミン;Phe:フエニルアラニ
ン;Met:メチオニン;Thr:スレオニン(以上
特に表示のない場合はアミノ酸はL体をさすもの
とし、D体はその旨明記する。但しGlyを除
く);Z:カルボベンゾキシ;Boc:t−ブトキ
シカルボニル;Et:エチル;HONBおよび
ONB:N−ハイドロキシ−5−ノルボルネン−
2,3−ジカルボキシイミドおよびそのエステ
ル;HOBt:N−ハイドロキシベンツトリアゾー
ル;DCC:N,N′−ジシクロヘキシルカルボジ
イミド;H2/Pd:接触還元;TFA:トリフルオ
ロ酢酸;CHA:シクロヘキシルアミン;
OTCP:2,4,5−トリクロロフエニルエステ
ル;OSu:N−ハイドロキシスクシンイミドエス
テル
実施例 1
(1) 2,3,5−トリメチルアニソールの合成
2,3,5−トリメチルフエノール10g、沃化
メチル10.4mlをジメチルスルフオキシド100mlに
とかし、氷冷し、これに、60%油性水酸化ナトリ
ウム5.6gを加え、10時間かきまぜる。これに水を
加えたのち、エーテルで抽出し、エーテル層は水
洗し、無水硫酸ナトリウムで乾燥する。溶媒を留
去すると、油状物を得る。収量12.9g(定量的)。
(2) 4−メトキシ−2,3,6−トリメチルベン
ゼンスルフオニルクロリドの合成
2,3,5−トリメチルアニソール4.5gを、塩
化メチレン500mlにとかし、−5゜〜−10℃に冷却し
たのち、クロルスルフオン酸6.0mlを含む塩化メ
チレン溶液400mlを滴下する。その後、室温にま
でもどし、5%炭酸水素ナトリウム水を含む氷上
にあける。塩化メチレン層は水洗したのち、無水
硫酸マグネシウムで乾燥する。溶媒を留去したの
ち、n−ヘキサンより結晶として、ろ取する。収
量5.0g(67.0%)
融点 56−58℃
元素分析 C10H13O3SClとして
計算値:C,48.29;H,5.27;S,12.89;Cl,
14.26
実験値:C,48.42;H,5.21;S,12.61;Cl,
14.25
参考例 1
Z−Arg(Mtr)OH・CHAの合成
(1) Z−Arg OH 2.83gを4N−水酸化ナトリウ
ム水10ml、アセトン40mlの混合液にとかし、氷
冷する。これに4−メトキシ−2,3,6−ト
リメチルベンゼンスルフオニルクロリド4.0gを
含むアセトン溶液10mlを加え、3時間かきまぜ
る。クエン酸酸性として、アセトンを留去し、
酢酸エチルで抽出する。溶媒を留去すると、油
状物4.8gを得るので、これを少量の酢酸エチル
にとかしシクロヘキシルアミン1.04mlを加えて
結晶としてろ取し、MeOH−酢酸エチルより
再結晶する。収量4.10g(72.1%)。
融点 195−197℃
[α]23 D +6.5゜(C=1.18,MeOH)
元素分析 C30H45O7N5Sとして
計算値:C,58.14;H,7.32;N,11.30;S,
5.17
実験値:C,58.08;H,7,34;N,11.58;
S,5.32
(2) H−Arg(Mtr)−OHの合成
Z−Arg(Mtr)−OH・CHA 1.5gを酢酸エチル
30mlにケンダクし、これに0.2N−H2SO4 15mlを
加えてよく振りまぜ水洗する。溶媒を留去したの
ち、残留物をメタノールにとかしPd黒を触媒と
して接触還元を行なう。触媒をろ去し、溶媒を留
去し、残留物に水を加えると、結晶化するので、
これをろ取する。収量0.77g(81%)。
融点 100−103℃
[α]23 D −4.8゜(C=1.30,MeOH)
元素分析 C16H26O5N4S・1/2H2Oとして
計算値:C,48.59;H,6.88:N,14.18;S,
8.11
実験値:C,48.78;H,7.16;N,13.88;S,
8.29
試験例
H−Arg(Mtr)−OH約20mgをトリフルオロ酢
酸−チオアニソール(9:1)2mlにとかし、表
1に示すような各条件で放置したのち、その
100μをとり、全体を10mlに秤量し、アミノ酸
分析を行ない、生成したアルギニンの量を測定し
た。結果を表1にした。In order to produce a peptide using a raw material compound (such as arginine) containing [Formula], it is necessary to protect the guanidino group. Protection of the guanidino group has conventionally been carried out by introducing a nitro group or a tosyl group. In these conventional methods, the yield when removing the protecting group is low, and in order to remove the tosyl group, it must be carried out under strong conditions using liquid ammonia-metallic sodium or anhydrous hydrogen fluoride. As a result, other parts of the peptide are separated and by-products are generated, resulting in a decrease in the yield of the desired peptide. The present inventors have proposed a method to overcome these drawbacks by first using p-methoxybenzenesulfonyl, meditylenesulfonyl, etc., which can be easily removed with methanesulfonic acid, as a protecting group for the guanidino group. (Japanese Unexamined Patent Publication No. 1973-100030) was introduced and put into practical use. After that, the present inventors continued their research on the protection of guanidino groups, and found that 4-methoxy-2,3,
It was discovered that the protective group of 6-trimethylbenzenesulfonyl group can be removed by further mild acid treatment, and the arginine derivative of the present invention useful for peptide production was completed. That is, the present invention provides 4-methoxy-2,3,6
-trimethylbenzenesulfonyl halide. The compound of the present invention is a guanidino group-containing compound,
For example, by introducing the guanidino group of arginine, the following general formula () It is used in peptide synthesis as an arginine derivative represented by the formula (wherein R represents H or a protecting group for an α-amino group). 4-Methoxy-2,3,6-trimethylbenzenesulfonyl halide includes chloride,
Any of fluoride, bromide, and iodide may be used. For example, 4-methoxy-2,3,6-trimethylbenzenesulfonyl chloride can be converted into an isomer by reacting 2,3,5-trimethylanisole with chlorsulfonic acid, as shown in the example below. , it can be obtained as a crystal without forming. 4- of the guanidino group of a guanidino group-containing compound
When introducing a methoxy-2,3.6-trimethylbenzenesulfonyl group, the α-amino group of the guanidino group-containing compound is protected and subjected to the reaction. The α-amino group can be protected using conventionally known protective groups, such as carbobenzoxy group, p-nitrobenzyloxycarbonyl group, p-methoxybenzyloxycarbonyl group, t-butoxycarbonyl group, t-amyloxycarbonyl group, 9-fluorenylmethoxycarbonyl group, isonicotinyloxycarbonyl group, O-nitrophenylsulfenyl group, 2-(p-biphenyl)-isopropyloxycarbonyl group Examples include those in which arginine is introduced by a conventional method, and those in which arginine is protected with a carbobenzoxy group or a t-butoxycarbonyl group are particularly advantageously used. Next, 4-methoxy-2,
3,6-trimethylbenzenesulfonyl group is reacted. In this reaction, 4-methoxy-2,3,6-trimethylbenzenesulfonic acid group is added to the guanidino group-containing compound in an amount of about 1 to 5 equivalents, more preferably about 1 to 2 equivalents per equivalent of the guanidino group-containing compound.
It is best to react in equivalent amounts. The introduction of the 4-methoxy-2,3,6-trimethylbenzenesulfonyl group is preferably carried out in the presence of a base. Examples of bases include sodium hydroxide,
Potassium hydroxide, lithium hydroxide, etc. are mentioned, and about 1 to 1 equivalent of guanidino group-containing compound is used.
10 equivalents are used, more preferably about 1 to 5 equivalents. The reaction is usually carried out in a suitable solvent such as water, acetone, dioxane, dimethylformamide, tetrahydrofuran, or a mixed solvent thereof. The reaction is carried out at -10°C to 25°C,
It is preferably carried out at -5°C to 10°C. 4-methoxy-2 obtained in this way,
A compound having a guanidino group protected by a 3,6-trimethylbenzenesulfonyl group is subjected to peptide condensation either as a free form or as a salt of cyclohexylamine, dicyclohexylamine, sodium, etc. according to a conventional method. In the present invention, a compound having a guanidino group protected with a 4-methoxy-2,3,6-trimethylbenzenesulfonyl group refers to an arginine derivative represented by the above general formula () and a salt thereof. be. 4-methoxy-2 obtained in this way,
A compound having a guanidino group protected with a 3,6-trimethylbenzenesulfonyl group is used in a peptide condensation reaction by a conventional method. For example, M. Bodansky and M.A.
Ondetti, Peptide Synthesis
Synthesis), Inter science.New York, 1966
Year; The Proteins by FMFinn and K. Hofmann, Volume 2, H. Nenrath, RL
Edited by Hill, Academic Press Inc. New york,
1976; “Peptide Synthesis” by Nobuo Izumiya et al. Maruzen Co., Ltd.
Methods described in 1975, such as the azide method, chloride method, acid anhydride method, mixed acid anhydride method,
DCC method, active ester method, Woodward reagent K
, the carbodiimidazole method, the redox method, and the DCC/HONB method. Next, after peptide condensation, the protecting group of the present invention is removed with an acid. As this desorption method, known acid treatment methods such as anhydrous hydrogen fluoride method, methanesulfonic acid method, and trifluoromethanesulfonic acid method can be applied. Furthermore, in the case of the method of the present invention, trifluoroacetic acid can be advantageously used as a new acid treatment method, and in particular, when trifluoroacetic acid is used in the presence of thioanisole or anisole, the elimination reaction proceeds very favorably. The above-mentioned trifluoroacetic acid, thioanisole, and anisole may be used in amounts sufficient to remove the protecting group as a solvent. For example, 1 to 1 equivalent of a compound having a protected guanidino group
10 5 equivalents, more preferably 1 to 10 3 equivalents are used, and the elimination reaction may be carried out in a solvent such as acetic acid, chloroform, methylene chloride, etc., and the temperature is about -10°C to 300°C, more preferably 10℃
It is carried out at a temperature of about 100°C. The compounds of the present invention are applicable to the production of any peptide having a guanidino group. A specific example is Des−Gly 10 −[D−eu 6 ]−LH−RH−
ethylamide (see Special Publication No. 53-14072), Des-Gly 10
-LH-RH-ethylamide (see Japanese Patent Publication No. 53-24423), Tuftsin [see Nature, 228672 (1970)],
Physiologically active peptides such as Substance P.Kyotorphin can be advantageously produced. Other peptides include MSH, ACTH, Glucagon Secretin
Bradykinin, Dynorphin, α-Neoendorphin and their active fragments can also be advantageously produced. The 4-methoxy-2,3,6-trimethylbenzenesulfonyl group can be easily removed not only by the conventional method of removing the guanidino protecting group by acid treatment but also under milder conditions. For example, mild acid treatments such as trifluoroacetic acid cannot be applied to remove conventionally known guanidino protecting groups, but 4-methoxy-
When protected with a 2,3,6-trimethylbenzenesulfonyl group, elimination proceeds well and can be applied satisfactorily. By the way, by the conventional method, after protecting the guanidino group with a p-methoxybenzenesulfonyl group or meditylenesulfonyl group and condensing the peptide,
When removing a protecting group using methanesulfonic acid, succinimide-type side reactions may occur if the peptide contains asparagine or aspartic acid residues, and serine or threonine residues may occur. In the presence of , N→O acyl rearrangement occurs. In the method of the present invention, even peptides containing these amino group residues can be removed by using a mild acid such as trifluoroacetic acid without causing side reactions as described above. Next, the present invention will be explained in more detail with reference to Examples and Test Examples. In this specification, 4-methoxy-2,3,6-trimethylbenzenesulfonyl group may be abbreviated as Mtr, and regarding amino acids, peptides, protecting groups, active groups, etc., the IUPAC-IUB commission on Biological
It may be indicated by an abbreviation based on nomenclature or by an abbreviation commonly used in the field. Illustrate them. pGlu: pyroglutamic acid; His: histidine;
Trp: tryptophan; Ser: serine; Tyr: tyrosine; Leu: leucine; Gly: glycine;
Arg: Arginine; Pro: Proline; Lys: Lysine; Gl N : Glutamine; Phe: Phenylalanine; Met: Methionine; Thr: Threonine (Unless otherwise specified, amino acids refer to the L-form, and the D-form (Excluding Gly); Z: Carbobenzoxy; Boc: t-butoxycarbonyl; Et: Ethyl; HONB and
ONB: N-hydroxy-5-norbornene-
2,3-dicarboximide and its ester; HOBt: N-hydroxybenztriazole; DCC: N,N'-dicyclohexylcarbodiimide; H2 /Pd: catalytic reduction; TFA: trifluoroacetic acid; CHA: cyclohexylamine;
OTCP: 2,4,5-trichlorophenyl ester; OSu: N-hydroxysuccinimide ester Example 1 (1) Synthesis of 2,3,5-trimethylanisole 2,3,5-trimethylphenol 10g, methyl iodide 10.4 Dissolve ml in 100ml of dimethyl sulfoxide, cool on ice, add 5.6g of 60% oily sodium hydroxide, and stir for 10 hours. After adding water to this, it is extracted with ether, and the ether layer is washed with water and dried over anhydrous sodium sulfate. Evaporation of the solvent gives an oil. Yield 12.9g (quantitative). (2) Synthesis of 4-methoxy-2,3,6-trimethylbenzenesulfonyl chloride Dissolve 4.5 g of 2,3,5-trimethylanisole in 500 ml of methylene chloride and cool to -5° to -10°C. , dropwise add 400 ml of methylene chloride solution containing 6.0 ml of chlorsulfonic acid. Thereafter, the mixture was brought to room temperature and placed on ice containing 5% sodium bicarbonate water. The methylene chloride layer is washed with water and then dried over anhydrous magnesium sulfate. After distilling off the solvent, the crystals are collected by filtration from n-hexane. Yield 5.0g (67.0%) Melting point 56-58℃ Elemental analysis C 10 H 13 O 3 Calculated value as SCl: C, 48.29; H, 5.27; S, 12.89; Cl,
14.26 Experimental value: C, 48.42; H, 5.21; S, 12.61; Cl,
14.25 Reference Example 1 Synthesis of Z-Arg(Mtr)OH・CHA (1) Dissolve 2.83 g of Z-Arg OH in a mixture of 10 ml of 4N sodium hydroxide and 40 ml of acetone, and cool on ice. To this was added 10 ml of an acetone solution containing 4.0 g of 4-methoxy-2,3,6-trimethylbenzenesulfonyl chloride, and the mixture was stirred for 3 hours. As citric acid acidifies, acetone is distilled off,
Extract with ethyl acetate. When the solvent is distilled off, 4.8 g of an oil is obtained. This is dissolved in a small amount of ethyl acetate, 1.04 ml of cyclohexylamine is added, the crystals are collected by filtration, and recrystallized from MeOH-ethyl acetate. Yield 4.10g (72.1%). Melting point 195-197℃ [α] 23 D +6.5゜ (C=1.18, MeOH) Elemental analysis C 30 H 45 O 7 N 5 Calculated value as S: C, 58.14; H, 7.32; N, 11.30; S,
5.17 Experimental value: C, 58.08; H, 7, 34; N, 11.58;
S, 5.32 (2) Synthesis of H-Arg(Mtr)-OH Add 1.5 g of Z-Arg(Mtr)-OH・CHA to ethyl acetate.
Dilute to 30ml, add 15ml of 0.2N-H 2 SO 4 , shake well, and wash with water. After distilling off the solvent, the residue was dissolved in methanol and subjected to catalytic reduction using Pd black as a catalyst. When the catalyst is filtered off, the solvent is distilled off, and water is added to the residue, it will crystallize.
Filter this out. Yield 0.77g (81%). Melting point 100-103℃ [α] 23 D -4.8゜ (C=1.30, MeOH) Elemental analysis C 16 H 26 O 5 N 4 S・1/2H 2 O Calculated value: C, 48.59; H, 6.88: N , 14.18;S,
8.11 Experimental value: C, 48.78; H, 7.16; N, 13.88; S,
8.29 Test Example Approximately 20 mg of H-Arg(Mtr)-OH was dissolved in 2 ml of trifluoroacetic acid-thioanisole (9:1) and left under the conditions shown in Table 1.
A 100 μ sample was taken, the whole was weighed to 10 ml, and amino acid analysis was performed to measure the amount of arginine produced. The results are shown in Table 1.
【表】
この結果、Mtr基は、TFA−チオアニソール
系では23℃で約1時間でも充分切断可能である。
参考例 2
(1) Boc−Tyr−Arg(Mtr)−OH
H−Arg(Mtr)−OH 0.80をテトラヒドロフラ
ン20mlにとかし、冷時、トリエチルアミン0.34
ml、Boc−TyrrONB(Boc−Tyr−OH 0.57g、
HONB 0.40g、DCC 0.50gより調製)を加えて
室温で15時間かきまぜる。溶媒を留去したのち、
クエン酸で酸性として、酢酸エチルで抽出する。
酢酸エチル層を水洗したのち溶媒を留去し、クロ
ロホルムにとかしてシリカゲルカラム(4×6
cm)に付す。5%MeOH/CHCl3で溶出し、目
的物の画分を集め、濃縮しエーテルより粉末とし
てろ取する。収量0.67g(51.5%)
融点 114−121℃
[α]23 D +1.2゜(C=0.4、ジメチルホルムアミ
ド)
元素分析 C30H43O9N5として
計算値:C,55.45;H,6.67;N,10.78;S,
4.94
実験値:C,55.12;H,6.83;N,10.53;S,
4.54
(2) H−Tyr−Arg−OH(Kyotorphin)の合成
Boc−Tyr−Arg(Mtr)OH 400mgをトリフル
オロ酢酸−チオアニソール(9:1)5mlにとか
し、室温で2時間放置する。トリフルオロ酢酸を
減圧で留去したのち、残留物にエーテルを加え
て、生ずる沈澱をろ取する。これを少量の水にと
かし、アンバーライトIRA−410(酢酸型)のカラ
ム(1×10cm)を通したのち凍結乾燥する。これ
を少量の水にとかし、カルボキシメチルセルロー
スのカラム(2.2×8cm)に付したのち、水(300
ml)と0.1M酢酸アンモニウム(300ml)の間で直
線勾配をかけて溶出を行なう。100〜150mlの画分
を集めて、凍結乾燥を行なう。収量175mg。
[α]21 D −17.4゜(C=0.5、H2O)
アミノ酸分解(酸分解):Arg 1.00(1);Tyr 0.94
(1) 平均回収率86.5%。
参考例 3
(1) Z−Arg(Mtr)−Pro−Lys(Boc)−Pro−
OHの合成
H−Pro−OMeにZ−Lys(Boc)−ONBとZ−
Pro−ONBを順次縮合することにより合成した
油状のZ−Pro−Lys(Boc)−Pro−OMe 0.59gを
メタノール30mlにとかし、パラジウム黒を触媒と
して、接触還元を行なう。触媒をろ別し、ろ液を
濃縮したのち、残留物をジメチルホルムアミド10
mlにとかし、これにZ−Arg(Mtr)OH・[Z−
Arg(Mtr)・OH・CHA 0.56gより調製]、HOBt
0.15g、DCC 0.23gを加え室温で15時間かきまぜ
る。生じたDCUをろ去し、溶媒を留去したのち、
残留物を酢酸エチルにとかし、重曹水、0.2N塩
酸で洗浄する。乾燥後、溶媒を留去し、残留する
油状物[Z−Arg(Mtr)Pro−Lys(Boc)−Pro−
OMe]を10mlのメノールに溶解する。冷時2ml
の1N−水酸化ナトリウム水を加え、室温で2時
間ケン化を行なう。1N−塩酸2mlを冷時加えて
中和し、メタノールを留去したのち、析出した油
状物を酢酸エチルで抽出する。溶媒を留去したの
ち、石油ベンジンを加えて粉末としてろ取し、酢
酸エチル−エーテルより再沈澱する。収量610mg
(66.1%)、融点90−95℃
[α]23 D −32.7゜(C=0.6、ジメチルホルムアミ
ド)
元素分析 C43H70O12N8Sとして
計算値:C,55.94;H,7.64;N,12.14;S,
3.47
実験値:C,55.62;H,7.56;N,11.98;S,
3.19
(2) H−Arg−Pro−Lys−Pro−GlN−GlN−Phe
−Phe−Gly−Leu−Met−NH2(Substance
P)の合成
Boc−GlN−GlN−Phe−Phe−Gly−Leu−Met
−NH2 0.49gをトリフルオロ酢酸(4.5ml)−水
(05ml)の混液にとかし、10℃で20分間ふりまぜ
る。0.5mlの1N−塩酸を加えて留去し、残留物に
エーテルを加えて粉末としてろ取し乾燥する。こ
れをジメチルホルムアミド15mlにとかし、冷時ト
リエチルアミン0.1mlを加え、さらにZ−Arg
(Mtr)−Pro−Lys(Boc)−Pro−OH 0.45g、
HONB 0.18g、DCC 0.20gを加えそのまゝ24時
間かきまぜる。生成したDCUをろ去し、ろ液を
濃縮する。残留物は水を加え、生じた沈でんをろ
取する。この100mgをとり、トリフルオロ酢酸−
チオアニソール(9:1)1mlにとかし、50℃で
1時間振りまぜたのちトリフルオロ酢酸を減圧で
留去し、残留物にエーテルを加えて、生ずる沈で
んをろ取し、乾燥する。これを少量の水にとか
し、アンバーライト−IRA−410(酢酸型)のカラ
ム(1×10cm)を通したのち凍結乾燥する。これ
をセフアデツクスG−25のカラム(2.5×120cm)
に付し、30%酢酸水で溶出する。主要溶出画分
(230〜260ml)を集めて、凍結乾燥する。収量58
mg
[α]23 D −78.8゜(C=0.5、5%酢酸)
アミノ酸分析(酸分解):Lys 1.00(1);Arg 1.04
(1);Glu 2.05(2);Pro 2.20(2);Gly 0.91(1);
Met 0.89(1);Leu 1.05(1);Phe 1.89(2)、平
均回収率82.3%。[Table] As a result, the Mtr group can be sufficiently cleaved in the TFA-thioanisole system even at 23°C for about 1 hour. Reference example 2 (1) Boc-Tyr-Arg(Mtr)-OH H-Arg(Mtr)-OH 0.80 is dissolved in 20ml of tetrahydrofuran, and when cold, triethylamine 0.34
ml, Boc-TyrONB (Boc-Tyr-OH 0.57g,
(prepared from 0.40g of HONB and 0.50g of DCC) and stir at room temperature for 15 hours. After distilling off the solvent,
Acidify with citric acid and extract with ethyl acetate.
After washing the ethyl acetate layer with water, the solvent was distilled off, dissolved in chloroform, and transferred to a silica gel column (4 x 6
cm). Elute with 5% MeOH/CHCl 3 , collect fractions of the desired product, concentrate and filter off as a powder from ether. Yield 0.67g (51.5%) Melting point 114-121℃ [α] 23 D +1.2゜ (C = 0.4, dimethylformamide) Elemental analysis C 30 H 43 O 9 N 5 Calculated value: C, 55.45; H, 6.67 ;N, 10.78;S,
4.94 Experimental value: C, 55.12; H, 6.83; N, 10.53; S,
4.54 (2) Synthesis of H-Tyr-Arg-OH (Kyotorphin) 400 mg of Boc-Tyr-Arg(Mtr)OH is dissolved in 5 ml of trifluoroacetic acid-thioanisole (9:1) and left at room temperature for 2 hours. After the trifluoroacetic acid is distilled off under reduced pressure, ether is added to the residue and the resulting precipitate is filtered. This is dissolved in a small amount of water, passed through a column (1 x 10 cm) of Amberlite IRA-410 (acetic acid type), and then freeze-dried. This was dissolved in a small amount of water and applied to a carboxymethyl cellulose column (2.2 x 8 cm), and then water (300
ml) and 0.1M ammonium acetate (300 ml). Fractions of 100-150 ml are collected and lyophilized. Yield 175mg. [α] 21 D −17.4° (C=0.5, H 2 O) Amino acid decomposition (acid decomposition): Arg 1.00(1); Tyr 0.94 (1) Average recovery rate 86.5%. Reference example 3 (1) Z−Arg(Mtr)−Pro−Lys(Boc)−Pro−
Synthesis of OH H-Pro-OMe, Z-Lys(Boc)-ONB and Z-
0.59 g of oily Z-Pro-Lys(Boc)-Pro-OMe synthesized by successive condensation of Pro-ONB was dissolved in 30 ml of methanol, and catalytic reduction was performed using palladium black as a catalyst. After filtering off the catalyst and concentrating the filtrate, the residue was dissolved in dimethylformamide 10
ml and add Z−Arg(Mtr)OH・[Z−
Prepared from 0.56g of Arg (Mtr)・OH・CHA], HOBt
Add 0.15g and 0.23g of DCC and stir at room temperature for 15 hours. After filtering off the generated DCU and distilling off the solvent,
Dissolve the residue in ethyl acetate and wash with aqueous sodium bicarbonate and 0.2N hydrochloric acid. After drying, the solvent was distilled off and the remaining oil [Z-Arg(Mtr)Pro-Lys(Boc)-Pro-
OMe] in 10 ml of menol. 2ml when cold
Add 1N aqueous sodium hydroxide and saponify at room temperature for 2 hours. After cold addition of 2 ml of 1N hydrochloric acid to neutralize, methanol was distilled off, and the precipitated oil was extracted with ethyl acetate. After distilling off the solvent, petroleum benzine was added and the powder was collected by filtration and reprecipitated from ethyl acetate-ether. Yield 610mg
(66.1%), melting point 90-95℃ [α] 23 D -32.7゜ (C = 0.6, dimethylformamide) Elemental analysis C 43 H 70 O 12 N 8 Calculated value as S: C, 55.94; H, 7.64; N ,12.14;S,
3.47 Experimental value: C, 55.62; H, 7.56; N, 11.98; S,
3.19 (2) H−Arg−Pro−Lys−Pro−Gl N −Gl N −Phe
−Phe−Gly−Leu−Met−NH 2 (Substance
Synthesis of P) Boc-Gl N -Gl N -Phe-Phe-Gly-Leu-Met
-Dissolve 0.49 g of NH 2 in a mixture of trifluoroacetic acid (4.5 ml) and water (0.5 ml) and stir at 10°C for 20 minutes. Add 0.5 ml of 1N hydrochloric acid and evaporate, add ether to the residue, filter it as a powder, and dry. Dissolve this in 15 ml of dimethylformamide, add 0.1 ml of triethylamine when cold, and add Z-Arg.
(Mtr)-Pro-Lys(Boc)-Pro-OH 0.45g,
Add 0.18g of HONB and 0.20g of DCC and stir for 24 hours. The generated DCU is filtered off and the filtrate is concentrated. Add water to the residue and filter the resulting precipitate. Take 100mg of this and trifluoroacetic acid-
Dissolve in 1 ml of thioanisole (9:1) and shake at 50°C for 1 hour. Trifluoroacetic acid is distilled off under reduced pressure. Ether is added to the residue, and the resulting precipitate is filtered and dried. This is dissolved in a small amount of water, passed through an Amberlite-IRA-410 (acetic acid type) column (1 x 10 cm), and then freeze-dried. Column of Sephadex G-25 (2.5 x 120cm)
and eluted with 30% acetic acid water. The main elution fractions (230-260 ml) are collected and lyophilized. Yield 58
mg [α] 23 D −78.8° (C = 0.5, 5% acetic acid) Amino acid analysis (acid decomposition): Lys 1.00(1); Arg 1.04
(1); Glu 2.05(2); Pro 2.20(2); Gly 0.91(1);
Met 0.89(1); Leu 1.05(1); Phe 1.89(2), average recovery 82.3%.
Claims (1)
ゼンスルフオニルハライド。1 4-Methoxy-2,3,6-trimethylbenzenesulfonyl halide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63285563A JPH01151549A (en) | 1988-11-10 | 1988-11-10 | 4-methoxy-2,3,6-trimethylbenzenesulfonyl halide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63285563A JPH01151549A (en) | 1988-11-10 | 1988-11-10 | 4-methoxy-2,3,6-trimethylbenzenesulfonyl halide |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56000560A Division JPS57114565A (en) | 1980-02-12 | 1981-01-05 | Preparation of peptide, and arginine derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01151549A JPH01151549A (en) | 1989-06-14 |
JPH0232273B2 true JPH0232273B2 (en) | 1990-07-19 |
Family
ID=17693172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63285563A Granted JPH01151549A (en) | 1988-11-10 | 1988-11-10 | 4-methoxy-2,3,6-trimethylbenzenesulfonyl halide |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01151549A (en) |
-
1988
- 1988-11-10 JP JP63285563A patent/JPH01151549A/en active Granted
Non-Patent Citations (1)
Title |
---|
PEPT CCEM * |
Also Published As
Publication number | Publication date |
---|---|
JPH01151549A (en) | 1989-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007099656A1 (en) | Method of producing peptide | |
JP5515738B2 (en) | Dibenzofulvene derivative method | |
EP1179537B1 (en) | Solid phase peptide synthesis method | |
JPH0357118B2 (en) | ||
JPS5973574A (en) | Cyclic dipeptide | |
Hiskey et al. | Sulfur-containing polypeptides. XV. Synthetic routes to the A6-13 segment of ovine insulin | |
US3870694A (en) | Peptide synthesis with n-hydroxy-5-norbornene-2,3-dicarboximide | |
CA1177826A (en) | Method for protecting guanidino group and restoring the same | |
JPH0223543B2 (en) | ||
JPH0232273B2 (en) | ||
JPH0228599B2 (en) | ||
JPH0210146B2 (en) | ||
JPS6346759B2 (en) | ||
JPH0120146B2 (en) | ||
JPH036160B2 (en) | ||
JPH072760B2 (en) | Reactive solid-phase carrier having an allyl side chain for solid-phase synthesis of peptides, glycopeptides and amino acids and method for producing the same | |
JPS6358822B2 (en) | ||
STÜBER et al. | Synthesis and photolytic cleavage of bovine insulin B22–30 on a nitrobenzoylglycyl‐poly (ethylene glycol) support | |
JPS6251280B2 (en) | ||
EP0217804A1 (en) | Analogs of substances p. | |
JPS6120560B2 (en) | ||
JPS6345399B2 (en) | ||
JPH0224835B2 (en) | ||
SEMENOV et al. | Synthesis of the partially protected fragment 1–16 of salmon calcitonin by using the phenylhydrazide protecting group | |
JPH0224836B2 (en) |